BRAF inhibition with concomitant tumor treating fields for a multiply progressive pleomorphic xanthoastrocytoma

od Lukas, Rimas V, Merrell, Ryan T
Izdano u CNS Oncol (2018)

NT-15 STEREOTACTIC LASER THERMAL ABLATION OF RECURRENT POSTERIOR FOSSA METASTATIC LESION: DESCRIPTION OF NEW TECHNOLOGY FOR INFRATENTORIAL TUMORS REFRACTORY TO CONVENTIONAL THERAPI...

od Eliyas, Javed Khader, Bailes, Julian, Merrell, Ryan, O'Leary, Shaun
Izdano 2014

MNGI-03. PATIENT PARAMETERS ASSOCIATED WITH TUMOR GROWTH IN INCIDENTAL MENINGIOMA

od Kamson, David, Yuen, Carlen, Castillo-Saavedra, Laura, Wilmington, Andrew, Walker, Matthew, Merrell, Ryan
Izdano u Neuro Oncol (2018)

Multifocal and Multicentric Glioblastoma with Leptomeningeal Gliomatosis: A Case Report and Review of the Literature

od Shakur, Sophia F., Bit-Ivan, Esther, Watkin, William G., Merrell, Ryan T., Farhat, Hamad I.
Izdano 2013

Combined Open and Endoscopic Endonasal Skull Base Resection of a Rare Endometrial Carcinoma Metastasis

od Stamates, Melissa M., Lee, John M., Merrell, Ryan T., Shinners, Michael J., Wong, Ricky H.
Izdano u J Neurol Surg Rep (2018)

MNGI-03. ESTROGEN HORMONE REPLACEMENT THERAPY IN INCIDENTAL MENINGIOMA - A GROWTH RATE ANALYSIS

od Kamson, David, Yuen, Carlen, Castillo Saavedra, Laura, Jenkins Vogel, Tilley, Merrell, Ryan, Walker, Matthew
Izdano u Neuro Oncol (2019)

Estrogen hormone replacement therapy in incidental intracranial meningioma: a growth-rate analysis

od Dresser, Laura, Yuen, Carlen Amy, Wilmington, Andrew, Walker, Matthew, Vogel, Tilley Jenkins, Merrell, Ryan T., Kamson, David Olayinka
Izdano u Sci Rep (2020)

Standardizing Care of Neuro-oncology Patients Using a Customized Electronic Medical Record Toolkit

od Merrell, Ryan T., Simon, Kelly Claire, Martinez, Nina, Vazquez, Rosa Maria, Hadsell, Bryce, Epshteyn, Alexander, Wilk, Gary, Frigerio, Roberta, Maraganore, Demetrius M.
Izdano u Mayo Clin Proc Innov Qual Outcomes (2021)

RT-08 PROTON THERAPY (PT) LARGE-VOLUME RE-IRRADIATION FOR RECURRENT GLIOMA: OVERALL SURVIVAL (OS) AND TOXICITY OUTCOMES

od Desai, Brijal, Rockne, Russell, Rademaker, Alfred, Raizer, Jeffrey, Paleologos, Nina, Merrell, Ryan, Grimm, Sean, Azeem, Syed, Hartsell, William, Sweeney, Patrick, Swanson, Kristin, Gondi, Vinai
Izdano u Neuro Oncol (2014)

PATH-29. MOLECULAR DETERMINANTS ASSOCIATED WITH RESPONSE AND RESISTANCE TO DEPATUXIZUMAB MAFODOTIN (ABT-414) IN PATIENTS WITH RECURRENT GLIOBLASTOMA

od Lassman, Andrew, Roberts-Rapp, Lisa, He, Lei, Lu, Xin, van den Bent, Martin, Papadopoulos, Kyriakos, Merrell, Ryan, Kumthekar, Priya, Reardon, David, Gomez, Erica, Fischer, JuDee, Jiang, Fang, Zha, Zheng, Bhathena, Anahita, Holen, Kyle, Ansell, Peter, Gan, Hui K, Scott, Andrew
Izdano u Neuro Oncol (2017)

ATCT-34 BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB PLUS VORINOSTAT VERSUS BEVACIZUMAB ALONE IN ADULTS WITH RECURRENT GLIOBLASTOMA

od Wu, Jing, Puduvalli, Vinay K., Yuan, Ying, Armstrong, Terri, Walker, Brenda, Upshaw, Charlene, Giglio, Pierre, Colman, Howard, Groves, Morris D., Raizer, Jeffrey, Walbert, Tobias, Tran, David, Avgeropoulos, Nicholas, Iwamoto, Fabio, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Paleologos, Nina, Fink, Karen, Gilbert, Mark R.
Izdano u Neuro Oncol (2015)

GENE-23. PREVIOUSLY IDENTIFIED COMMON GLIOMA RISK SNPs ARE ASSOCIATED WITH FAMILIAL GLIOMA

od Ostrom, Quinn, Armstrong, Georgina, Amos, Christopher, Bernstein, Jonine, Claus, Elizabeth, Eckel-Passow, Jeanette, Il’yasova, Dora, Johansen, Christoffer, Lachance, Daniel, Lai, Rose, Merrell, Ryan, Olson, Sara, Schildkraut, Joellen, Shete, Sanjay, Houlston, Richard, Jenkins, Robert, Wrensch, Margaret, Melin, Beatrice, Barnholtz-Sloan, Jill, Bondy, Melissa
Izdano u Neuro Oncol (2018)

ET-19 A PHASE 1 STUDY EVALUATING ABT-414 WITH TEMOZOLOMIDE (TMZ) OR CONCURRENT RADIOTHERAPY (RT) AND TMZ IN GLIOBLASTOMA (GBM)

od Gan, Hui K., Fichtel, Lisa, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Kumthekar, Priya, Scott, Andrew M., Pedersen, Michelle, Gomez, Erica, Fischer, JuDee, Ames, William, Xiong, Hao, Dudley, Matt, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Reardon, David A.
Izdano 2014

ATNT-01 ABT-414 MONO- OR COMBINATION THERAPY WITH TEMOZOLOMIDE (TMZ) RECHALLENGE IN PATIENTS WITH RECURRENT GLIOBLASTOMA (GBM) AND AMPLIFIED EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR)...

od Gan, Hui K., Kumthekar, Priya, Lassman, Andrew B., Merrell, Ryan, van den Bent, Martin, Papadopoulos, Kyriakos P., Scott, Andrew M., Gomez, Erica, Fischer, JuDee, Mandich, Helen, Xiong, Hao, Lee, Ho-Jin, Munasinghe, Wijith, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle, Lai, Rose, Reardon, David A.
Izdano u Neuro Oncol (2015)

ATNT-02 DETERMINANTS OF RESPONSES AND RESISTANCE TO ABT-414: RESULTS OF NEXT-GENERATION SEQUENCING

od Scott, Andrew M., Roberts-Rapp, Lisa, Gan, Hui K., Lu, Xin, Lassman, Andrew B., van den Bent, Martin, Papadopoulos, Kyriakos P., Merrell, Ryan, Kumthekar, Priya, Reardon, David A., Sokolova, Irina, Song, Minghao, Kular, Rupinder, Gomez, Erica, Fischer, JuDee, Bhathena, Anahita, Holen, Kyle, Lai, Rose, Ansell, Peter
Izdano u Neuro Oncol (2015)

Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma

od Reardon, David A., Lassman, Andrew B., van den Bent, Martin, Kumthekar, Priya, Merrell, Ryan, Scott, Andrew M., Fichtel, Lisa, Sulman, Erik P., Gomez, Erica, Fischer, JuDee, Lee, Ho-Jin, Munasinghe, Wijith, Xiong, Hao, Mandich, Helen, Roberts-Rapp, Lisa, Ansell, Peter, Holen, Kyle D., Gan, Hui K.
Izdano u Neuro Oncol (2017)

ACTR-13. A BAYESIAN ADAPTIVE RANDOMIZED PHASE II TRIAL OF BEVACIZUMAB VERSUS BEVACIZUMAB PLUS VORINOSTAT IN ADULTS WITH RECURRENT GLIOBLASTOMA FINAL RESULTS

od Puduvalli, Vinay, Wu, Jing, Yuan, Ying, Armstrong, Terri, Wu, Jimin, Giglio, Pierre, Xu, Jihong, Colman, Howard, Walbert, Tobias, Raizer, Jeffrey, Groves, Morris, Iwamoto, Fabio, Tran, David, Avgeropoulos, Nicholas, Paleologos, Nina, Fink, Karen, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Penas-Prado, Marta, Yung, W K Alfred, Gilbert, Mark
Izdano u Neuro Oncol (2018)

ATCT-22 NRG ONCOLOGY/RTOG 1122: PHASE II DOUBLE-BLINDED, PLACEBO-CONTROLLED STUDY OF BEVACIZUMAB WITH OR WITHOUT AMG 386 IN PATIENTS WITH RECURRENT GLIOBLASTOMA OR GLIOSARCOMA

od Lee, Eudocia Q., Zhang, Peixin, Wen, Patrick Y., Gerstner, Elizabeth R., Reardon, David A., Aldape, Ken, de Groot, John F., Choe, Kevin S., Raizer, Jeffrey J., Kim, Lyndon J., Chmura, Steven J., Robins, H. Ian, Connelly, Jennifer, Battiste, James, Villano, John, Wagle, Naveed, Merrell, Ryan T., Wendland, Merideth, Mehta, Minesh P.
Izdano u Neuro Oncol (2015)

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

od Puduvalli, Vinay K, Wu, Jing, Yuan, Ying, Armstrong, Terri S, Vera, Elizabeth, Wu, Jimin, Xu, Jihong, Giglio, Pierre, Colman, Howard, Walbert, Tobias, Raizer, Jeffrey, Groves, Morris D, Tran, David, Iwamoto, Fabio, Avgeropoulos, Nicholas, Paleologos, Nina, Fink, Karen, Peereboom, David, Chamberlain, Marc, Merrell, Ryan, Penas Prado, Marta, Yung, W K Alfred, Gilbert, Mark R
Izdano u Neuro Oncol (2020)

EPID-01 CHICKEN POX AND GLIOMA RISK: PRELIMINARY RESULTS FROM THE GLIOGENE INTERNATIONAL CASE-CONTROL STUDY

od Amirian, E. Susan, Scheurer, Michael, Armstrong, Georgina, Zhou, Renke, Lau, Ching, Claus, Elizabeth, Barnholtz-Sloan, Jill, Il'yasova, Dora, Schildkraut, Joellen, Ali-Osman, Francis, Sadetzki, Siegal, Johansen, Christoffer, Houlston, Richard, Jenkins, Robert, Lachance, Daniel, Olson, Sara, Bernstein, Jonine, Merrell, Ryan, Wrensch, Margaret, Davis, Faith, Lai, Rose, Shete, Sanjay, Amos, Christopher I., Melin, Beatrice S., Bondy, Melissa
Izdano u Neuro Oncol (2015)